Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
European Journal of Haematology|February 8, 2014
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplantRahma Warsame, Soo Mee Bang, Shaji K Kumar, et al.
Blood|January 12, 2012
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogeneticsShaji Kumar, Rafael Fonseca, Rhett P Ketterling, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Blood|June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
American Journal of Hematology|May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of boneRahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 6, 2011
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantationSandra M S Herrmann, Morie A Gertz, Mark D Stegall, et al.
Mayo Clinic Proceedings|October 3, 2007
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myelomaMartha Q Lacy, Morie A Gertz, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013
Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myelomaPrashant Kapoor, Shaji K Kumar, Angela Dispenzieri, et al.
Pageof 10